Holen Sie sich die Stockscreener-App
6.45
8.07%
0.50
Schlusskurs vom Vortag:
$5.95
Offen:
$6.11
24-Stunden-Volumen:
130.38K
Relative Volume:
0.52
Marktkapitalisierung:
$234.46M
Einnahmen:
$16.10M
Nettoeinkommen (Verlust:
$-42.57M
KGV:
-4.5735
EPS:
-1.4103
Netto-Cashflow:
$-38.53M
1W Leistung:
+24.85%
1M Leistung:
-15.51%
6M Leistung:
+31.49%
1J Leistung:
+10.48%
1-Tages-Spanne:
$5.92
$6.50
1-Wochen-Bereich:
$5.19
$6.70
52-Wochen-Spanne:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.46 | 215.95M | 16.10M | -42.57M | -38.53M | -1.4103 |
ABT
Abbott Laboratories
|
102.53 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.44 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.60 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.06 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone - marketscreener.com
If You Invested $1,000 in Profound Med Corp (PROF) - Stock Titan
Profound Medical (NASDAQ:PROF) Trading Down 1.7%Time to Sell? - MarketBeat
Profound Medical (TSE:PRN) Stock Price Down 2.6%Time to Sell? - MarketBeat
Income Plays: Is Profound Medical Corp showing insider buyingStop Loss & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Profound Medical Touts Positive Trial Results for MRI-Guided TULSA Procedure - Medical Product Outsourcing
Profound Medical Marks Key TULSA Milestone as Texas Prostate Tops 100 Procedures - TipRanks
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone - The Manila Times
Dallas prostate center says Medicare shift lifted TULSA cases 500% - Stock Titan
Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains? - Yahoo Finance
Q2 2025 Profound Medical Corp Earnings Call Transcript - gurufocus.com
Trading Action: How does Profound Medical Corp perform in inflationary periodsWeekly Trade Recap & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Dip Buying: Is Profound Medical Corp showing insider buying2026 Review & Daily Stock Momentum Reports - baoquankhu1.vn
Precision Trading with Profound Medical Corp. (PROF) Risk Zones - news.stocktradersdaily.com
Top 3 Health Care Stocks That Are Set To Fly In March - Benzinga
Profound Medical stock rating reiterated by Raymond James on trial data - Investing.com India
Returns Recap: Can Profound Medical Corp sustain its profitability2026 Macro Moves & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Profound Medical reports CAPTAIN trial meets primary safety endpoint - Yahoo Finance
Profound Medical's (PROF) TULSA Procedure Shows Superior Safety Outcomes - GuruFocus
Profound Medical Corp. Reports Results of CAPTAIN Trial Comparing MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy - marketscreener.com
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence - Bitget
Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes - TipRanks
Profound Medical (PROF) trial: TULSA tops robotic surgery on key safety outcomes - Stock Titan
Prostate trial: MRI-guided TULSA helps more men keep sex and bladder control - Stock Titan
Aug Outlook: What hedge funds are buying Profound Medical Corp2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
Profound Medical Announces Board Resignation and New Appointment - TipRanks
Medical Co.'s TULSA-PRO Installed Base Growth & CAPTAIN Trial Data Could Accelerate Adoption in 2026 - Streetwise Reports
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 - Investing News Network
Profound Medical to Host Investor Call March 13 on First CAPTAIN Trial Outcomes Presented at EAU 2026 - TradingView
Profound Medical (PROF) Awaits Key Clinical Data Presentation - GuruFocus
Profound Medical to Present First CAPTAIN Trial Results and Steps Up Investor Outreach - TipRanks
Profound Medical (NASDAQ: PROF) sets call on CAPTAIN trial data - Stock Titan
(PRN) Technical Pivots with Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript - Insider Monkey
Profound Medical (TSX:PRN) Narrowing EPS Loss In Q3 2025 Tests Growth Optimism Narrative - simplywall.st
History Review: Can Profound Medical Corp beat the S P 500Market Volume Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Street Watch: Is OVBC forming a bullish divergenceEarnings Performance Report & Verified Swing Trading Watchlist - baoquankhu1.vn
Profound Medical (TSE:PRN) Trading Down 26%Time to Sell? - MarketBeat
Profound Medical reports net loss of USD 8.2M in Q4 2025 - Medical Buyer
Profound Medical (NASDAQ:PROF) Issues Earnings Results - MarketBeat
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: R - GuruFocus
Profound Medical Q4 Earnings Call Highlights - Yahoo Finance
Aug Sentiment: Can Profound Medical Corp beat the S P 500July 2025 Weekly Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises - Investing.com South Africa
Profound Medical (PROF) Reports Q4 Revenue Below Expectations - GuruFocus
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Profound Medical Posts Record Q4 Revenue as TULSA-PRO Adoption and Global Expansion Accelerate - TipRanks
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Profound Medical Corp-Aktie (PROF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):